Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
13 October 2020 | Story Ruan Bruwer | Photo BackpagePix
Khanyisa Chawane, a Protea player, should be one of the stars for the Free State Crinums in the Telkom Netball League. She was the Player of the League in 2018.
Having to play 11 matches in so many days before the knockout stage will be a daunting task, but their fitness levels are up to standard, says the coach of the Free State netball team. Burta de Kock of KovsieSport will again guide the Free State Crinums in the Telkom Netball League, which will be taking place between 14 and 27 October in Bloemfontein.

All but one of the 12 members of the team are studying at the University of the Free State (UFS).

“Planning will be of the utmost importance to manage the load on the players. We also have four players (Rolene Streutker, Chanel Vrey, Boitumelo Mahloko, and Refiloe Nketsa) who will participate in the South African U21 team that will play five invitational matches during the competition,” said De Kock.

In previous years, the competition took place over four to six weeks, but now it had to be fitted into two weeks due to COVID-19.

“So, it will be a tall order to play so many matches, but an exciting challenge. I believe the hard work the players had put in during the lockdown period will bear fruit. They were exceptional and very determined to stay in shape.”

The Crinums won the first three years of the competition, but couldn’t reach the final in the following three years. Apart from the 11 Kovsies in the Crinums team, there are 9 current or former UFS students in other teams participating in the league. 

They are Zandré Smit, Bianca Pienaar, Dané Klopper, Arné Fourie, Bethenie du Raan (all Northern Cape Diamonds), Maryke Coetzee, Danelle van der Heever (both Mpumalanga Sunbirds), Rieze Straeuli (Western Cape Tornados), and Alicia Puren (KZN Kingdom Stars).

The Crinums team: Boitumelo Mahloko, Ané Retief, Jana Scholtz, Khanyisa Chawane, Lefébre Rademan (captain), Sikholiwe Mdletshe, Claudia van den Berg, Bianca de Wee, Rolene Streutker, Chanel Vrey, Lerato Chabwe, and Refiloe Nketsa.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept